Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Bifidobacterium porcinum - : Escherichia coli Nissle 1917 {Mutaflor} |
👶
Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917. World journal of gastroenterology (World J Gastroenterol ) Vol: 22 Issue 23 Pages: 5415-21 Pub: 2016 Jun 21 Epub: Authors Manzhalii E , Hornuss D , Stremmel W , Html Article Publication |
| Increases Bifidobacterium porcinum - : Escherichia coli Nissle 1917 {Mutaflor} |
👶
Modulation of gut microbiome in response to the combination of Escherichia coli Nissle 1917 and sugars: a pilot study using host-free system reflecting impact on interpersonal microbiome. Frontiers in nutrition (Front Nutr ) Vol: 11 Issue Pages: 1452784 Pub: 2024 Epub: 2024 Oct 22 Authors Heer K , Kaur M , Sidhu D , Dey P , Raychaudhuri S , Html Article Publication |
| Decreases Bifidobacterium porcinum - : Escherichia coli Nissle 1917 {Mutaflor} |
👶
Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment. World journal of hepatology (World J Hepatol ) Vol: 14 Issue 3 Pages: 634-646 Pub: 2022 Mar 27 Epub: Authors Manzhalii E , Moyseyenko V , Kondratiuk V , Molochek N , Falalyeyeva T , Kobyliak N , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
